Lawrence N Kwong

13PUBLICATIONS
179CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 18, 2026
Proteogenomic profiling identifies FGFR2b as a prevalent cell-surface target in intrahepatic cholangiocarcinoma.

|Jun 26, 2026
Personalized targeting of BCL2 family proteins overcomes acquired resistance to BRAF-MEK inhibitors in preclinical melanoma.

|May 18, 2026
FGFR1 but not S6K1/2 drives intrinsic BRAF inhibitor resistance in melanoma.

|May 13, 2026
A Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities and Immune Architecture.

|Apr 02, 2026
Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy.

Joseph Abi Jaoude, Alexandria Lau, Yinyin Yuan

|Nov 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract Cancers.

Xin Wang, Jaime Ivan Haro-Silerio, Felix E G Beaudry

Pageof 3

Frequent Collaborators

6 joint publications

Milind M Javle

4 joint publications

Funda Meric-Bernstam

3 joint publications

Hop Tran Cao

3 joint publications

Alexander J Lazar